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Analysis of hematopoietic stem cell function in
nonhuman primates provides insights that are rele-
vant for human biology and therapeutic strategies.
In this study, we applied quantitative genetic bar-
coding to track the clonal output of transplanted
autologous rhesus macaque hematopoietic stem
and progenitor cells over a time period of up to
9.5 months. We found that unilineage short-term pro-
genitors reconstitutedmyeloidand lymphoid lineages
at 1monthbutweresupplantedover timebymultiline-
age clones, initially myeloid restricted, then myeloid-
B clones, and then stable myeloid-B-T multilineage,
long-term repopulatingclones.Surprisingly, reconsti-
tution of the natural killer (NK) cell lineage, and partic-
ularly the major CD16+/CD56 peripheral blood NK
compartment, showed limited clonal overlap with T,
B, or myeloid lineages, and therefore appears to be
ontologically distinct. Thus, in addition to providing
insights into clonal behavior over time, our analysis
suggests an unexpected paradigm for the relation-
ship between NK cells and other hematopoietic line-
ages in primates.
INTRODUCTION
Understanding how hematopoietic stem and progenitor cells
(HSPCs) produce a diversity of blood and tissue cell lineages
at a high rate for the life of an individual, under homeostatic
control, without exhaustion, and with only rare catastrophic
neoplastic dysregulation has been a major investigative focus.
Insights have been translated into a myriad of clinical advances,
including hematopoietic stem cell (HSC) transplantation,
cytokine treatment of cytopenias, and targeted therapies for he-
matopoietic neoplasms. Despite such progress, however, many486 Cell Stem Cell 14, 486–499, April 3, 2014 ª2014 Elsevier Inc.issues remain to be investigated, including the degree of homo-
geneity of long-term self-renewing HSCs, the difficulty of
modeling hematopoietic lineage ontogenies in vitro, the control
of fate decisions, the patterns of the contributions of individual
cells in vivo over time, and the number and lifespan of true
HSCs (Copley et al., 2012). Murine HSCs have been character-
ized at close to a single-cell level in gold-standard transplanta-
tion assays via cell-surface phenotype and gene-expression
profiling (Osawa et al., 1996; Smith et al., 1991; Spangrude
et al., 1988; Weissman and Shizuru, 2008). Limit-dilution trans-
plantation experiments define what one or a few stem cells can
do, but whether HSC behavior in this setting of extraordinary
replicative stress fully mimics normal steady-state hematopoie-
sis or even nonlimit-dilution transplantation is questionable.
Transduction of HSPCs with integrating viral vectors results in
passage of the integrated provirus to every daughter cell. Each
semirandom viral integration site (VIS) serves as a unique clonal
‘‘tag’’ for individual HSPCs and their progeny. Pioneering studies
in mice identified VISs via Southern blot and provided evidence
for multilineage clonal repopulation by single cells (Jordan and
Lemischka, 1990); however, this insensitive approach detects
only dominant clones and cannot resolve highly polyclonal
patterns or investigate contributions to cells from less abundant
lineages, such as natural killer (NK) cells. A number of more sen-
sitive PCR-based VIS retrieval methods have been devised, but
all have limitations regarding both efficiency and quantitation
(Berry et al., 2012; Bushman et al., 2005; Schmidt et al., 2002;
Wu et al., 2013). An alternative is to generate high-diversity len-
tiviral libraries to deliver a unique ‘‘barcode’’ to individual HSPCs,
allowing quantitative clonal tracking. This concept was devel-
oped to study murine antigen-specific T cell dynamics and
extended to proof-of-concept studies in murine HSPCs (Gerrits
et al., 2010; Schepers et al., 2008). In our previous study (Lu
et al., 2011), we combined lentiviral barcoding with PCR retrieval
and high-throughput sequencing to elucidate the behavior of
HSPCs in mice. The results showed that clonal output from indi-
vidual cells can be assessed in a sensitive and quantitative
manner, and yielded important insights into murine hematopoi-
etic lineage bias.
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(Baum et al., 1992; Doulatov et al., 2012). Limit-dilution trans-
plantation or vector tagging of human HSPCs in immunodefi-
cient mice has provided valuable information regarding the
phenotype of human engrafting cells and some information
about their behavior in vivo (Doulatov et al., 2012; Guenechea
et al., 2001; Larochelle et al., 1996). However, the behavior of
human cells in mice is far from physiologic, given the reliance
on a xenogeneic niche, with little release of fully differentiated
progeny into the blood and very limited development of T or
NK cells (Coulombel, 2004). Hematopoiesis in rodents is mark-
edly different from that in large animals or humans with regard
to cytokine utilization, location of stress hematopoiesis, HSPC
phenotype and frequency, and lifetime hematopoietic demand
(Abkowitz et al., 1996, 2002; Catlin et al., 2011; Larochelle
et al., 2011; Shepherd et al., 2007).
We have utilized rhesus macaque autologous transplantation
to investigate HSPC behavior in a model with direct relevance
to humans (Donahue and Dunbar, 2001). Humans and ma-
caques are phylogenetically close, with comparable lifespans,
hematopoietic demand, and HSPC frequencies (Shepherd
et al., 2007). We can efficiently mark rhesus HSPCs with lentiviral
vectors and track marked progeny cells for many years (Kim
et al., 2009). We now report the use of lentiviral HSPC barcoding
to track and quantitate clonal contributions following autologous
rhesus HSPC transplantation, and provide multiple insights
into hematopoietic reconstitution and lineage hierarchies, most
notably of NK cells.
RESULTS
Experimental Design and Validation
In order to track in vivo output from individual HSPCs in the
rhesus macaque, we adapted our lentiviral cellular barcoding
technology to rhesus CD34+ HSPCs and followed clonal output
following myeloablative autologous transplantation (Figure 1A).
Highly diverse DNA barcode libraries were cloned into lentiviral
vectors that also contained a GFP marker. Using mixtures of
single-copy barcoded K562 cell clones, we showed that the
retrieved barcode frequency quantitatively reflects the contribu-
tion of an individual clone within a polyclonal mixture over a
range of ratios (Figure S1 available online).
Mobilized peripheral blood (PB) CD34+ cells from three ma-
caques were transduced with barcoded vectors, and 7.8–16.7
million autologous GFP+ cells were reinfused following ablative
total body irradiation (Figure 1B). Vector barcode diversity was
assessed following retrieval of barcodes from transduced rhesus
cells at the end of transduction, and Monte Carlo simulations
using these experimental data were performed to ask whether
the library diversity was sufficient to ensure with high confidence
that a single barcode labeled a single cell (Figure S2; Lu et al.,
2011). Based on the best available prior estimate for the fre-
quency of rhesus repopulating cells (i.e., 5 per 100,000 CD34+
cells), the barcoded libraries chosen had at least 10-fold higher
diversity than was required to be more than 95% certain that a
single barcode marked only one HSPC clone at these trans-
planted doses (Kim et al., 2000; Shepherd et al., 2007).
For the most straightforward tracking of individual HSPCs, the
presence of only a single barcode per cell is desirable; thus, wetargeted a maximum CD34+ transduction efficiency of no more
than 30%–35%, based on prior models (Kustikova et al., 2003;
Verovskaya et al., 2013). The level of GFP positivity in circulating
blood cells from myeloid and lymphoid lineages following trans-
plantation is shown in Figure 1C. As expected, granulocytes (Gr)
and monocytes (Mo) counts recovered rapidly, within 2 weeks of
transplantation, followed by NK, B, and then T cells, and reached
normal levels by 3–6 months. We found that 10%–30% of
hematopoietic cells in all lineages were GFP+ in ZH33 and
ZG66, and stabilized by 2–3 months in Gr, Mo, B, and NK cells,
with transduced T cell engraftment lagging behind (Figure 1C),
reflecting slower replacement of endogenous T cells as we
observed previously (An et al., 2007). ZH17 showed a similar
pattern but overall much lower marking. It stabilized at levels of
only 1%–2% despite receiving CD34+ cells with the same trans-
duction efficiency as the other two animals, likely reflecting
greater competition from endogenous HSPCs that survived
radiation, due to differences in radiation sensitivity between indi-
vidual macaques.
Following engraftment, PB and lymph nodes were collected at
various time points, and Gr, Mo, T, B, NK, and plasmacytoid and
myeloid dendritic cells (DCs) were flow sorted (purity median
98.8%; Figure S3; Table S1). The mean barcode copy number
per individual transduced HSPC in individual colonies (colony-
forming units [CFUs]) derived from CD34+ cells plated at the
end of transduction in animal ZH33 was 1.2 ± 0.22 (SEM), and
1.07 ± 0.07 in CFUs grown from CD34+ cells obtained from the
bone marrow (BM) of ZH33 following engraftment, with only
7% of CFUs containing two copies and none containing more
than two (Figure 2A). We also compared vector copy number
and % GFP+ cells in PB posttransplantation in all three animals
(Figure 2B), and the mean copy number per GFP+ cell was
1.04 ± 0.04. In total, these data confirm that the majority of trans-
duced cells contained only one barcode. A minority of clones
containing more than one barcode would skew calculations of
the frequency of repopulating clones upward, but would not
impact analysis of lineage contributions or kinetics.
Barcode retrieval by PCR, Illumina sequencing, and custom
data analysis was performed on purified hematopoietic lineage
samples monthly for 9.5 months (ZH33), 6.5 months (ZH17),
and 4.5 months (ZG66) (Lu et al., 2011). Our algorithms extract
barcodes by library IDs, account for sequencing misreads and
indels, quantitate valid reads for each barcode, and create a
master list of barcodes for each animal, consisting of barcodes
present in at least one sample at a read number over cutoffs
determined for each animal to exclude 99.5% of ‘‘false’’ artifac-
tual barcodes (see the python code in Supplemental Experi-
mental Procedures, and the master list of barcodes and
contributions to each lineage and time point in Table S4). Very
high reproducibility of barcode retrieval and quantitation was
demonstrated via sequencing and PCR replicates on the same
DNA samples (Figure S4).
We assayed independently processed replicate blood sam-
ples to identify a lower barcode read threshold that would result
in 95% barcode retrieval between replicates. This method was
designed to exclude false negatives arising from sampling error
related to the number of cells (mean of 70,000 cells processed
to yield 200 ng DNA) in each purified sample (Figure S4). For
the highly marked animals ZH33 and ZG66, the majority ofCell Stem Cell 14, 486–499, April 3, 2014 ª2014 Elsevier Inc. 487
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Figure 1. Experimental Design and Clonal Diversity
(A) Oligonucleotides consisting of a library ID followed by a random barcode were cloned into a lentiviral vector flanked by PCR primer sites. Mobilized PB
autologous CD34+ cells were transduced and infused back into the irradiated autologous macaque, and PB, BM, and lymph node samples were collected,
purified by fluorescence-activated cell sorting (FACS), and barcode retrieval was performed via PCR and high-throughput sequencing. Information relevant to the
methods used is presented in Figures S1–S4 and Tables S1–S3.
(B) Transduction and transplantation parameters for rhesus macaques ZH33, ZH17, and ZG66.
(C) Percentage of GFP+ cells in PB lineages over time following transplantation.
(D) Number of independent barcoded clones detected in the PB (combined B, T, Gr, Mo, NK) at each time point (m, months).
(E) Cumulative number of independent barcoded clones detected in PB (combined B, T, Gr, Mo, NK) over time.
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Figure 2. Barcode Copy Number per HSPC Clone
(A) Barcode copy number in individual CFUs obtained at the end of transduction (left, n = 48) or frommarrow CFUs posttransplantation from ZH33 (right, n = 14).
(B) Barcode copy number per transduced cell for PB samples. The molecular marking level (vector copy number) was determined by qPCR on sorted GFP-
negative granulocytes (GFPGr), GFP-positive granulocytes (GFP+ Gr), and sorted T, B, and NK cells from ZH33, ZH17, and ZG66, and plotted on the left panel
(white bars) next to the fraction of GFP+ cells in the same sample as assessed by FACS (green bars). A ratio of 1 implies one vector copy per each GFP+ cell. On
the right, the ratios of molecular marking level determined by copy number PCR/GFP marking level for all samples from each of the three animals (mean ± SEM)
are shown.
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Quantitative Tracking of Rhesus Hematopoiesisbarcoded hematopoiesis derived from clones above this
threshold, and only clones above the threshold were included
in pairwise comparisons between lineages or time points.
ZH17, with a much lower overall in vivo marking level, was
not used for pairwise comparisons because its barcode read
threshold was at least 10-fold higher than in the other animals,
which limited our ability to compare low-abundance clones
between samples. However, individual abundant clones from
this animal were tracked and overall clone numbers were
scored.
Overall HSPC Clonal Diversity Posttransplantation
Figures 1D and 1E plot the number of unique barcodes that
contributed at each time point, and the cumulative number of
unique clones that were identified over time. A total of 976 indi-
vidual clones in ZH33 (9.5 months), 1,184 in ZH17 (6.5 months),
and 1,977 in ZG66 (4.5 months) were detected at one or more
time points, at a read number above the cutoff determined for
each animal set to exclude sequencing artifacts. Based on the
number of GFP+ cells transplanted (Figure 1B), 1 in 9,000
CD34+ cells contributed at any time point (range 1 in 6,500–11,300). This is a lower limit, given that low-contributing clones
were missed due to sampling constraints or excluded by
sequencing background cutoffs. The cumulative number of
clones detected began to plateau as early as 3–4 months
posttransplantation, with fewer new clones appearing after
that time point. At the longest follow-up in each animal (4.5–
9.5 months), the frequency of clones that were still contributing
was 2.5-fold lower: 1 in 22,000 CD34+ cells (range 1 in
17,000–30,000).
Lineage and Longitudinal Clonal Contributions
We assessed the fractional contributions of individual clones to
different hematopoietic lineages over time. As shown in Figure 3
(ZH33) and Figure S5 (ZG66), the fractional contribution of each
individual barcoded clone can be directly compared between lin-
eages and time points, and the distribution of lineage bias in the
population of clones can be assessed. The frequency of highly
biased clones (defined as >10-fold fractional representation of
a barcode in one lineage or time-point sample versus another),
as well as pairwise Pearson correlations between all lineages
and time points, can be quantified (Figure 4). Spearman analysisCell Stem Cell 14, 486–499, April 3, 2014 ª2014 Elsevier Inc. 489
Figure 3. Clonal Comparisons between Lineages
Scatterplots compare sequencing read fractions in ZH33 between pairs of lineages over time. Each dot represents an individual barcode/clone from the master
list, detected in either lineage. Green dots are barcodes with reads falling below the sampling threshold of 1,144 reads combined between the two lineages, and
(legend continued on next page)
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Figure 4. Summary of Clonal Lineage and Kinetic Relationships over Time
(A) Pearson correlation coefficients comparing barcode contributions for all barcodes that fall above the sampling threshold of 1,144 for pairwise comparisons,
between all lineages and time points, for animal ZH33 and ZG66 (r values and their associated p values and 95% confidence intervals are given in Table S5).
The color scale bar for r values is on the right. Slope indicates negative or positive correlation; the shape and the color signify the strength of the correlation.
MDCs, myeloid dendritic cells; PDCs, plasmacytoid dendritic cells; LN, lymph node. An alternative analysis utilizing Spearman correlation is shown in Figure S6
and Table S6.
(B) Fraction of highly biased (>10-fold greater fractional representation in one sample versus the other) barcodes between all lineages and time points for ZH33
and ZG66. Bias is toward the sample shown in the row and away from the sample in the column. The color scale is given on the right. The frequency of highly
biased clones in these comparisons differed significantly from the total frequency of highly biased clones at the time point combination (*p < 0.05). A hierarchical
clustering analysis for fractional barcode contributions in ZH33 and ZG66 is given in Figure S7.
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Quantitative Tracking of Rhesus Hematopoiesisof the data set gave essentially the same results, although
because of the different nature of the two tests, some patterns
of biological interest are not as apparent in the Spearman ana-
lyses (Figure S6).red dots are barcodes with reads above the threshold. The bias histograms are
measuring the angle from the axis for each barcode, and renormalizing from 1 t
bias bin is on the y axis, and the degree of bias is on the x axis, with clones having e
bias histograms without regard to its overall level of contribution. Analogous datAt 1 month posttransplantation, there was no correlation be-
tween lineages, with unilineage or extremely biased low-abun-
dance clones predominating. Clones that were contributing at
1 month did not persist in contributing substantially to anygenerated from the scatterplots for barcodes that fall above the threshold by
o 1 before placing each barcode into a bias bin. The number of clones in each
qual lineage contributions defined as zero. Each clone is counted equally for the
a from animal ZG66 are shown in Figure S5.
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Quantitative Tracking of Rhesus Hematopoiesislineage at 3 month or later (Figures 3 and 4), and thus were
defined as short-term, lineage-restricted progenitors. The first
bilineage Gr/Mo clones began to emerge at 2months and rapidly
dominated. By 3 months, virtually all Gr and Mo clones were
shared and there were few highly biased clones, directly demon-
strating in vivo output from common Gr/Mo progenitors. By
3 months, clones shared between myeloid (Gr/Mo) and B line-
ages began to dominate, with stronger correlations as well as
a decrease in highly biased Gr/Mo or B clones, before clones
contributing to T and B lineages appeared (Figures 3 and 4).
By 4.5–6.5 months, multilineage, less biased Gr/Mo/B/T clones
became dominant. CD11c+CD16+ and CD11c+CD16 myeloid
DCs, as well as CD11cCD123+ plasmacytoid DCs collected
at 6.5 months from ZH33, were most closely related to each
other and to the Gr/Mo myeloid lineages.
To further depict the complexities of the clonal contributions
to all lineages, we performed hierarchical clustering analysis
for ZH33 and ZG66 (Figure S7), which demonstrated grouping
of the 1 month samples separate from later time points for all lin-
eages, confirmed the close relationship betweenGr andMo, and
showed the lack of a clear grouping of B and T lineages separate
from myeloid lineages at any time point.
We also compared the clonal composition of blood versus
lymph node T and B cells in ZH33 (9.5 months) and ZG66
(3 months), and found shared clonal patterns of these lineages
in blood versus node (Figure 4), with a single expanded T cell
clone outlier in the PB of ZG66 accounting for almost 20% of
marked cells not found at a similar level in the one node sampled.
NK Cell Ontogeny
We were surprised to find a very different pattern of clonal
contributions in NK cells (Figures 4, 5, and S6). Between 3 and
6.5 months, when many shared Gr/Mo/T/B clones were contrib-
uting, NK clonal composition remained distinct, and then began
to converge toward the other lineages by 9.5 months (Figures 4
and 5). Highly biased clones predominated compared with the
other four lineages at the same time points. Triangle plots (Fig-
ure 6) confirmed the presence of highly skewed NK contributing
clones distinct from shared T and B contributing clones at
6.5 months (ZH33) or 4.5 months (ZG66), versus clusters of
clones contributing to T, B, and Gr at the same time points.
The extent of NK clonal diversity was similar to that in other lin-
eages in terms of the total number of clones; however, a number
of very high high-contributing clones dominated the PB at indi-
vidual time points.
We fractionated NK cells into distinct populations (the major
CD16+/CD56 PB fraction and the minor blood CD16/CD56+
fraction) at 6.5 months (ZH33) or 4.5 months (ZG66) (Figure 5B).
We also obtained lymph node NK cells from ZG66, which,
in contrast to PB NK cells, were primarily CD16/CD56+. The
CD16+/CD56 PB NK cells accounted for the clones that were
distinct from T/B/Gr/Mo lineages, as shown by bias plots, Pear-
son correlation coefficients, the fraction of highly biased
(>10-fold) clones, and both K-mean and hierarchical clustering
(Figure 5). Spearman correlation coefficients also supported
this result (Figure S6), although the Pearson correlation is more
biologically relevant. In contrast, the clonal patterns in the
CD16/CD56+ subsets of NK cells from blood and lymph nodes
strongly correlated with T/B/Gr/Mo lineages.492 Cell Stem Cell 14, 486–499, April 3, 2014 ª2014 Elsevier Inc.Analysis of Abundant Clones
In highly polyclonal samples, it is likely that some clones may still
intermittently fall below sampling detection limits despite the use
of thresholds set to exclude false negatives, complicating anal-
ysis of lineage contributions. Since we did not have sufficient
DNA to run duplicate samples on every lineage at every time
point, the thresholds that were set to exclude false-negative
bias due to sampling error were based on limited information.
Therefore, we also individually mapped the ten most abundant
clones identified in each lineage at 1 month, 3 months, and
longest follow-up (9.5 months [ZH33], 6.5 months [ZH17], and
4.5 months [ZG66]), tracking contributions from each clone
over all time points and in all other lineages (Figure 7). These
abundant clones are inherently interesting because they account
for a disproportionate fraction of ongoing hematopoiesis and are
less likely to be misinterpreted due to sampling error. Even the
most dominant clones at 1 month were primarily unilineage,
and ceased or greatly decreased their relative contributions by
2–3 months. T and B cells produced during initial lineage recov-
ery even from these highly productive clones disappeared or
greatly decreased at later time points.
The patterns were very different for the top clones at 3 months
and the top clones at longest follow-up, with the top Gr, Mo, T,
and B clones detected in the same lineage tracing back through
2 months, but not 1 month, and increasing in their relative contri-
butions over time between 2 months and 4.5–9.5 months as
short-term progenitor contributions decreased. A number of in-
dividual clones fell into the top ten clones for multiple lineages
at the later time points, with the most overlap among B, Gr,
and Mo; some overlap with T; and the least overlap with NK lin-
eages. This suggests that at least some clones were contributing
at relatively balanced and high levels to multiple lineages, con-
firming the patterns discerned at the population level. Some of
these clones also contributed to NK cells, but at much lower
levels compared with the relative contributions of the top ten
NK clones. The top NK clones from 3 months or latest follow-
up were not detected at equivalent or appreciable levels in the
other four lineages, further supporting the unique characteristics
of this lineage. In two of the animals, there was transient marked
expansion of one or more T cell clones at single time points, sug-
gesting a clonal response to an infection or other environmental
insult.
DISCUSSION
The application of HSPC barcoding in the rhesus model has
provided a number of new insights into large-mammal hemato-
poiesis. This approach is highly quantitative and requires only
small amounts of DNA that can be obtained from multiple line-
ages repeatedly over time from the same animal, in contrast
to the less efficient and quantitative VIS-retrieval-dependent ap-
proaches (Bushman et al., 2005). Barcoding relies on vector inte-
gration, which raises concerns about the impact on HSPC
behavior via activation of adjacent proto-oncogenes (Calmels
et al., 2005; Kustikova et al., 2005; Nienhuis et al., 2006). How-
ever, lentiviral vectors are much less likely to transform HSPCs
compared with murine retroviral vectors, due to lentiviral integra-
tion patterns and the deletion of endogenous enhancer se-
quences in these vectors (Modlich et al., 2009; Montini et al.,
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Figure 5. Clonal Contributions to NK Cells
(A) Scatterplots and bias plots for NK versus T, B, and Gr from ZH33 (6.5 months) and ZG66 (4.5 months).
(B) Example of FACS gating for sorting of NK subsets in blood (ZH33, 6.5 months) and node (ZG66, 3 months).
(C) Bias plots comparing CD16+ and CD56+ NK with B, T, and Gr from ZH33 at 6.5 months (left) and ZG66 at 4.5 months (right).
(D) Graphical summary of Pearson correlation coefficients (left) (Table S7 gives r values, p values, and 95% confidence intervals) and fractions of highly biased
(>10-fold difference in fractional representation) clones (right; *p < 0.05), comparing NK cells and subsets from the PB (ZH33, 6.5 months, upper panel) and from
ZG66 blood (4.5 months) and node (3 months, lower panel). An alternative analysis utilizing Spearman correlation is shown in Figure S6 and Table S7.
(E) Euclidian distance hierarchical clustering (upper panel) and K-mean clustering with k = 5 (lower panel), ZH33 (6.5 months), and ZG66 (4.5 months blood,
3 months node). For each animal, all barcodes on the master clone list are included. For K-mean clustering, the % of clones in each cluster is shown above the
plots. NK, NK cells in PB; LN-NK, lymph node NK; CD16+NK, CD16+CD56; CD56+NK, CD16CD56+.
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Figure 6. Triangle Plots of Clonal Contributions to T, B, NK, and Gr Lineages
Triangle plots of the clonal contributions to B, T, NK, and Gr in ZH33 at 6.5 months (A), and in ZG66 at 4.5 months (B). Each dot represents an individual barcoded
clone, with the size of the dots corresponding to the total fractional contribution of the individual barcode to the total barcodes retrieved at the time point. The
color of the dot is assigned randomly to help distinguish adjacent dots. The location of the barcode represents the ratio of barcode reads in each of the three cell
lineages. The presence of large dots clustering at the vertex of plots including NK cells suggests a unique population of highly biased NK clones in both animals, in
contrast to clusters of dots in the center of B/T/Gr triangles, suggesting common clones that contribute in a balanced manner to these lineages, particularly by
6.5 months in ZH33.
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Quantitative Tracking of Rhesus Hematopoiesis2009). Follow-ups of 5–10 years in rhesus macaques (Kim et al.,
2009, 2014) and over 3 years in human clinical trials revealed
stable polyclonal engraftment of lentiviral-transduced HSPC
without expansion of dominant clones (Biffi et al., 2011; Cartier
et al., 2009).
We believe that nonhuman primate models provide informa-
tion that is highly relevant to human hematopoiesis and difficult
to obtain in any other system. Immunodeficient mice lack a
physiologic niche for human hematopoiesis, exhibit inefficient
engraftment with adult HSPCs, show little maturation of T or
NK cells, and do not release human cells normally into the blood,
precluding most quantitative analyses of clonal HSPC output or
lineage hierarchies. In patients enrolled in clinical gene therapy
trials, hematopoiesis can be tracked long term via VIS identifica-
tion, but most of these patients will experience perturbations
due to activation of proto-oncogenes by murine retroviral
vectors, dysregulated expression of the therapeutic gene, or un-
derlying hematopoietic abnormalities (Deichmann et al., 2011;
Deichmann et al., 2007; Gabriel et al., 2009; Schwarzwaelder
et al., 2007). Our rhesus approach is not limited by these
constraints.
In our studies, CD34+ cells were selected prior to barcoding.
Virtually all HSPC engrafting activity in adult BM and mobilized
PB in humans and monkeys is within the CD34+ fraction
(Andrews et al., 2000; Doulatov et al., 2012). Long-term HSCs
are a minority of HSPCs, and human HSCs assayed in xeno-
grafts are CD34+38lo90+117+Lin (Majeti et al., 2007; Park
et al., 2008). Human CD34+ subfractions have been placed in a
hierarchy of multipotent progenitors (MPPs), lymphomyeloid-494 Cell Stem Cell 14, 486–499, April 3, 2014 ª2014 Elsevier Inc.biased progenitors (LGMPs), common lymphoid progenitors
(CLPs), common myeloid progenitors (CMPs), GM progenitors
(GMPs), megakaryocyte-erythroid progenitors (MEPs), and unili-
neage-restricted progenitors of the myeloerythroid lineages,
as assayed in vitro and in xenografts (Galy et al., 1995; Majeti
et al., 2007; Manz et al., 2002). Cell-surface markers that delin-
eate each of these subpopulations in the rhesus macaque
have not been rigorously identified; however, ourmodel will allow
prospective purification, barcoding, and autologous engraft-
ment of putative progenitor populations to define each subset
in an autologous, physiologic setting.
We calculate a minimum frequency for rhesus engrafting
HSPCs as 1 in 9,000 CD34+ cells, corresponding to 1 per
4.5 million mobilized PB mononucleated cells (PBMNCs). At
the longest follow-up (4.5–9.5 months), 1 in 22,000 CD34+
cells continued to contribute. Limit-dilution studies measured
the ‘‘SCID repopulating’’ HSPC frequency to be 1 in 6 million
mobilized human PBMNCs (Wang et al., 1997). The lower fre-
quency of primate or human repopulating cells in xenografts
as compared with direct autologous measurement may reflect
the inefficiency of xenogeneic engraftment. The majority of rhe-
sus clones found as early as 3 months were still contributing at
9.5 months, and only a small number of new clones appeared
for the first time after 3 months, suggesting that relatively stable
hematopoiesis may be achieved quite rapidly in a physiologic
autologous model, perhaps derived from the rhesus equivalent
of ‘‘intermediate’’ mouse repopulating HSCs (Benveniste et al.,
2010). This rapid clonal stability is in contrast to the much
more heterogeneous results that were recently obtained using
Figure 7. Tracking of Individual High-Contributing Clones
The fractional contribution of each barcode to the total barcodes retrieved from each lineage at each time point were ranked, and the top ten contributing
barcodes in each lineage at 1, 3, and 9.5 months from ZH33 (left column); 1, 3, and 6.5 months from ZH17 (middle column); and 1, 3, and 4.5 months from ZG66
(right column) were tracked for their contributions in all lineages over time. Each graph shows the time posttransplantation on the x axis, and the percentage of
total reads each clone contributes to the lineage is shown as a stacked graph on the y axis. Each y axis scale is linear and identical across each row of graphs, with
the scale on the far right of each row, but note that scale is adjusted between rows, in particular when one very dominant clone is being depicted. Clones shown in
grayscale are top ten in only one lineage. Clones shown in color are top ten in more than one lineage, and each clone has a unique color, allowing comparisons
between plots for each animal.
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likely resulting from inefficiencies of engraftment and hemato-
poietic output in that model (Cheung et al., 2013). The highly
polyclonal nature of reconstitution in the barcoded macaques
bypasses stochastic variations that arise in the setting of limiting
stem cell doses, which is predicted to result in very prolonged
periods of hematopoietic instability (Abkowitz et al., 1996).
However, hematopoietic tracking for much longer time periods
is required to determine the frequency and clonal output oftrue long-term repopulating cells, and to distinguish models
of HSC clonal exhaustion/succession versus clonal stability. A
related study from our primate program, published in this issue
(Kim et al., 2014), utilized very-long-term lentiviral VIS retrieval
to address some of these issues. Longer follow-up combined
with barcoding will allow additional highly quantitative analyses
of whether lineage-skewed classes of HSCs exist in nonhuman
primates, analogous to recent findings in murine models
regarding lymphoid versus myeloid biased HSCs and ourCell Stem Cell 14, 486–499, April 3, 2014 ª2014 Elsevier Inc. 495
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et al., 2014).
Our studies demonstrate the presence of unilineage engrafting
progenitors in all lineages, supporting prior results from murine
and xenograft models, and a recent paper utilizing barcoding
that demonstrated unilineage B, granulocytic, and dendritic
cell output from lymphoid primed multipotent progenitors
(LMPPs) (Guenechea et al., 2001; Jones et al., 1990; Jordan
and Lemischka, 1990; Naik et al., 2013). Highly purified ex vivo
cultured CD34+ cells do not contain viable mature T, B, or NK
cells at the time of reinfusion; thus, reestablishment of these
lineages must occur from CD34+ progenitor cells rather than
by peripheral expansion of mature barcoded cells. The ability
to at least transiently engraft lineage-restricted progenitors is
of interest for human transplantation applications, and ourmodel
can be applied to identify the phenotype of relevant transplant-
able progenitor cells. Output from these unilineage short-term
repopulating clones largely disappeared from the blood and
lymph node by 2–3 months, suggesting that the half-life of newly
producedmature B and T cells and their direct progenitors is sur-
prisingly short, at least in the posttransplantation setting.
As early as 2 months, Gr and Mo clonal architecture became
highly correlated, with shared and unbiased clones contributing,
confirming in vivo the close relationship between these lineages
revealed by in vitro assays. Beginning at 3months and continuing
through 9.5 months, myeloid and lymphoid lineages began to
share clonal patterns. However, the relationship between B and
myeloid cells was closer and was established more rapidly than
that betweenBandTcells. A recent analysis of the lineage poten-
tial of putative human HSPC populations suggested that the
majority of previously characterized multi-lymphoid progenitors
(MLPs), the human equivalent of CLPs, retain the ability to pro-
duce myeloid lineage cells in vitro and in xenografts (Doulatov
et al., 2010). A recent murine barcoding analysis did not find a
higher correlation between contributions of clones to T and B
than to myeloid and B cells (Verovskaya et al., 2013). We did
not document an appreciable set of clones contributing to
T and B, but not myeloid, lineages at any time during early
hematopoietic reconstitution, supporting the existence of an
MLP versus a CLP in primates. Multilineage clones appeared
by 3 months and continued to contribute to Gr/Mo/B/T lineages
through 9.5 months, with faster stabilization than reported in
xenografts, perhaps reflecting a more polyclonal and efficient
engraftment process in autologous macaques as compared
with human cells in murine niches (McKenzie et al., 2006).
Ourmost interesting findings concern the putative ontogeny of
NK cells. NK cells are defined by target cell killing and cytokine
production independent of priming or antigen/MHC restriction
(Caligiuri, 2008; Vivier et al., 2011). Rhesus NK cells have been
well characterized and share most (but not all) cell-surface
markers with human NK cells (Mavilio et al., 2005; Webster and
Johnson, 2005). The ability of both T and NK cells to lyse targets,
as well as some shared cell-surface receptors, has suggested
that they are ontologically related. In vitro, a humanNK-B precur-
sor hasbeen identified that is able toproduceboth lineagesunder
certain culture conditions. However, NK output from this progen-
itor, or from single MLPs able to produce T, B, NK, and myeloid
lineages in vitro, was not detected in xenografts (Doulatov
et al., 2010; Galy et al., 1995). The original studies that identified496 Cell Stem Cell 14, 486–499, April 3, 2014 ª2014 Elsevier Inc.a mouse CLP able to produce T, B, and NK cells in vitro did not
show clonal production of all three lineages in vivo (Kondo
et al., 1997). In mice, CLPs, as a population, do give rise to T,
B, and NK cells (Fathman et al., 2011; Karsunky et al., 2008).
In our model, as late as 6.5 months, the most abundant NK
clones made virtually no contributions to the other four lineages.
Analysis of NK subsets demonstrated that blood CD16+/CD56
NK cells accounted for the unique clonal pattern, distinct from
the other four lineages, and that the less abundant CD16/
CD56+ cells were more closely related to B/T/Gr/Mo lineages.
In vitro culture assays and comparisons of node versus blood
human NK cells have led to the hypothesis that lymph node
CD16/dim/CD56+ noncytotoxic cytokine-producing NK cells
are precursors to circulating cytotoxic CD16+/CD56/dim NK
cells (Caligiuri, 2008; Reeves et al., 2010). Our results instead
suggest separate origins for these two populations. It is of inter-
est that patients with GATA2 mutations and profoundly disor-
dered hematopoiesis characterized by abnormalities of myeloid
cells and B cells have an almost complete lack of CD16dim/
CD56+NK cells, but preservation of theCD16+/CD56dim NK pop-
ulation, which goes against the hypothesis that CD16dim/CD56+
cells are precursors of CD16+/CD56dim cells (Mace et al., 2013).
Alternatively, HSCs or other multipotent progenitors may land
in ‘‘NK niches,’’ specifically supporting NK development or pro-
liferation. Self-renewing NK precursors may exist; however, by
9.5 months, the NK cell clonal architecture began to be more
closely related to that of T/B/Gr/Mo, with shared clones contrib-
uting to all five lineages at appreciable levels. Finally, the most
abundant CD16+/CD56 clones in the PB might represent a
massive expansion of clones in response to specific environ-
mental stimuli, although the lack of contribution frommost major
NK clones in the T/B/Gr/Mo lineages, at any time point, makes
this possibility less likely. The ability to track NK clones via bar-
coding in vivo and in vitro opens new avenues of investigation
of this poorly understood lineage.
EXPERIMENTAL PROCEDURES
Generation of Barcoded Vectors
DNA barcodes consisting of a 6 bp library identifier followed by a 35 bp (ZH33
and ZG66) or 30 bp (ZH17) random barcode were produced from synthesized
oligonucleotides and cloned into the nonexpressing region of the HIV-derived,
replication-defective pCDH vector (System Biosciences; Lu et al., 2011; Fig-
ure 1A). High-diversity libraries suitable for efficient transduction of rhesus
macaque CD34+ cells were produced by calcium phosphate transfection of
293T cells with the barcoded lentiviral vector plasmid and cHIV helper plas-
mids (Uchida et al., 2009, 2012).
The diversity of the library was assessed via transduction of the rhesus cell
line LCL8864 and CD34+ primary cells, low-cycle PCR, Illumina sequencing,
custom python code processing, and quantitation of unique barcodes and
copy number per barcode (Figure S2). Monte Carlo simulation (Supplemental
Experimental Procedures) utilizing these experimental data was used to
determine the number of target cells that could be transduced with this vector
barcode library diversity, with various probabilities that >95% of retrieved
barcodes represent single cells (Lu et al., 2011).
Collection, Transduction, and Transplantation of CD34+ HSPCs
All animal studies were approved by the NHLBI Animal Care and Use Com-
mittee. Mobilization with granulocyte colony-stimulating factor and stem cell
factor (SCF), CD34+ cell collection and immunoselection, transduction, condi-
tioning, and transplantation were performed as previously described (Donahue
et al., 2005). CD34+ cells were cultured overnight on RetroNectin-coated
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of human Flt3 ligand, SCF, and thrombopoietin (R&DSystems), and 1%human
albumin, and transduced with barcode-containing lentiviral vectors at a multi-
plicity of infection (moi) of 25 in the presence of 4 mg/ml protamine sulfate
(Sigma). Transduced CD34+ cells were reinfused 24 hr later into the irradiated
(500 cGy/day for 2 days) autologous macaque.
Hematopoietic Cell Purification and Analysis
Mononuclear cells from lymph nodes were isolated by gentle mechanical
disruption of tissues and collagenase dissociation (Seggewiss et al., 2007).
PB cells were separated by Ficoll; stained with antibodies (Table S2) for Gr,
T, B, Mo, NK cells, NK subsets, and myeloid and plasmacytoid dendritic cells
(Gujer et al., 2011); and sorted on a FACSAria II instrument (Figure S3; for the
purities obtained, see Table S1). DNA was extracted with the DNeasy
Blood & Tissue Kit (QIAGEN) and quantified by NanoDrop. Quantitative
PCR (qPCR) was performed to determine vector copy number with an
ABI PRISM 7700 (Applied Biosystems) using the primers and probes listed
in Table S3.
Barcode Extraction, Sequencing, and Analysis
We subjected 200 ng (ZH33 and ZG66) or 500 ng (ZH17) of DNA to a first round
of 14-cycle PCR with primers bracketing the barcode, and a second round of
14 cycles with primers adding a sample ID to facilitate multiplex sequencing
(Table S3). Equal amounts of gel-purified product from individual samples
were pooled together for multiplex sequencing (Illumina HiSeq 2000). We pro-
cessed the sequencing output using custom python code (Supplemental
Experimental Procedures) to extract barcodes via library IDs, combining barc-
odes to allow for sequencing indels and mismatches up to 2 bp, and setting a
lower cutoff for read numbers to eliminate 99.5% of background ‘‘false barc-
odes’’ for each animal (Lu et al., 2011). Barcodes with total read numbers
smaller than these cutoffs (1,845 [ZH33], 1,686 [ZH17], and 541 [ZG66])
were eliminated, and a cumulative master list of barcodes with total reads
over these cutoffs was generated for each animal (Table S4). The raw
sequencing data from all time points and lineageswere then reanalyzed versus
this master list to pull out sequences representing these barcodes, allowing for
mismatches and indels up to 2 bp, and determining the final read number for
each barcode in each sample. The fractional representation of each barcode in
a sample was then calculated from the ratio of an individual barcode’s read
number divided by the total number of valid barcode reads (Table S4).
For all pairwise comparisons between samples collected from different lin-
eages or at different time points for ZH33 and ZG66, a combined read number
‘‘sampling’’ threshold was set to exclude 95% of clones that scored as falsely
‘‘biased’’ (>103 barcode ratio) between the replicate samples (Figure S4), and
was determined to be 1,144 based on the median value calculated for all avail-
able replicate samples (n = 10).
Computational and Statistical Analysis
Data analysis and plot generation were done using R code, ggplot2, corrplot,
and reshape2 software. Pearson and Spearman correlation coefficients were
calculated using R (R Foundation for Statistical Computing, Vienna, Austria;
ISBN 3-900051-07-0, http://www.R-project.org/). We calculated p values for
highly biased clones using Fisher’s exact test, comparing the frequency of
highly biased clones against the overall frequency of highly biased clones at
the time-point combination being considered.
For global analyses of clonal contributions via hierarchical clustering, we
applied three steps of normalization to the total data set consisting of the valid
read number for all barcodes: the fractional contribution of each barcode
to the overall reads in each individual sample, 75th percentile normalization,
and log10 transformation. Unsupervised two-way hierarchical clustering by
a Euclidean distance algorithm was applied to all samples. K-mean clustering
with a k = 5 was applied to all lineages at specific time points, filtering out any
barcodes that were not present in any sample prior to K-mean clustering.
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